Quetiapine Fumarate Tablet, Film Coated
Product Images NDC 71335-2394

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 71335-2394). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352394)

This is a description of Quetiapine Fumarate tablets containing 400 mg of quetiapine. Each film-coated tablet contains 460.488 mg of the active ingredient. The medication is intended for adult use, and it is important to keep it out of the reach of children. The recommended storage temperature is 20°C to 25°C, with excursions permitted to 15°C to 30°C. The medication is available by prescription only and should be dispensed with a medication guide to each patient. The tablets are repackaged by Bryant Ranch Prepack, Inc. and manufactured by Alkem Laboratories.*

FDA Label Image

Quetiapine-fig1 (Quetiapine Fig1)

The text provides a visual representation of the Kaplan-Mcier Curves showing the Time to Recurrence of a Mood Event in Study 7. The figure displays the proportion of patients experiencing a relapse over time (measured in weeks).*

FDA Label Image

Quetiapine-fig2 (Quetiapine Fig2)

FDA Label Image

Structure (Quetiapine Stru)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.